Romano-Zelekha Orly, Keren Dean, Herskovitz Yael, Vinograd Adi, Globus Inbal, Keinan-Boker Lital
Israel Center for Disease Control, Ministry of Health, Tel Hashomer, Ramat Gan, Israel.
Rappaport Faculty of Medicine, Technion Israel Institute of Technology, Haifa, Israel.
Surg Today. 2025 May;55(5):652-658. doi: 10.1007/s00595-024-02946-3. Epub 2024 Oct 9.
To compare postoperative anemia rates after one-anastomosis gastric bypass (OAGB) with those after sleeve gastrectomy (SG) in a large nationwide, population-based cohort study.
We sourced data from the Israeli Bariatric Surgery Registry. The study included a cohort of adults who underwent bariatric surgery (BS) between 2013 and 2017. Hemoglobin (Hb) was measured preoperatively and then 1 and 2 years post-BS. Anemia rates were compared between the patients who underwent OAGB and those who underwent SG, using multivariable analyses.
The study comprised 1,052 patients who underwent OAGB and 5,885 patients who underwent SG. Among them, 24.1% and 23.6% were men, respectively, and the preoperative mean body mass index values were 41.7 ± 5.0 and 42.1 ± 5.1 kg/m2, respectively. The 1-year and 2-year postoperative anemia rates were significantly higher after OAGB than after SG, when adjusted for age, pre-surgery BMI, sex and other covariates (1 year: 37.5% vs. 20.2%; adj-OR = 2.43; 95% CI 2.08-2.86; 2 years: 45.1% vs. 28.5%; adj-OR = 1.92; 95% CI 1.59-2.32).
Patients who underwent OAGB had significantly higher anemia rates 1 year and 2 years postoperatively than those who underwent SG. Consequently, vigilant surveillance and intervention strategies post-OAGB should be considered to mitigate the incidence of anemia and its associated complications.
在一项大规模的全国性、基于人群的队列研究中,比较单吻合口胃旁路术(OAGB)与袖状胃切除术(SG)后的术后贫血率。
我们从以色列肥胖症手术登记处获取数据。该研究纳入了2013年至2017年间接受肥胖症手术(BS)的成年人群队列。术前及术后1年和2年测量血红蛋白(Hb)。使用多变量分析比较接受OAGB的患者和接受SG的患者之间的贫血率。
该研究包括1052例行OAGB的患者和5885例行SG的患者。其中,男性分别占24.1%和23.6%,术前平均体重指数值分别为41.7±5.0和42.1±5.1kg/m²。在调整年龄、手术前BMI、性别和其他协变量后,OAGB术后1年和2年的贫血率显著高于SG术后(1年:37.5%对20.2%;调整后比值比=2.43;95%置信区间2.08 - 2.86;2年:45.1%对28.5%;调整后比值比=1.92;95%置信区间1.59 - 2.32)。
接受OAGB的患者术后1年和2年的贫血率显著高于接受SG的患者。因此,应考虑在OAGB术后采取警惕的监测和干预策略,以降低贫血及其相关并发症的发生率。